Selected physical and chemical properties of commercial Hypericum perforatum extracts relevant for formulated product quality and performance

Objective. The complex composition-activity relationship of botanicals such as St John's Wort (SJW) presents a major challenge to product development, manufacture, and establishment of appropriate quality and performance standards for the formulated products. As part of a larger study aimed at addressing that challenge, the goals of the present study are to (1) determine and compare the phytochemical profiles of 3 commercial SJW extracts; (2) assess the possible impact of humidity, temperature, and light on their stability; and (3) evaluate several physical properties important to the development of solid dosage forms for these extracts. Methods. An adapted analytical method was developed and validated to determine phytochemical profiles and assess their stability. The extract physical properties measured were particle size (Malvern Mastersizer), flow (Carr's compressibility index; minimum orifice diameter), hygroscopicity (method of Callahan et al), and low-pressure compression physics (method of Heda et al). Results. The phytochemical properties differed greatly among the extracts and were extremely sensitive to changes in storage conditions, with marked instability under conditions of elevated humidity. All extracts exhibited moderate to free-flow properties and were very hygroscopic. Compression properties varied among the extracts and differed from a common use excipient, microcrystalline cellulose. Conclusions. Three commercial sources of SJW extracts exhibited different physical and chemical properties. Standardization to 1 or 2 marker compounds does not ensure chemical equivalence nor necessarily equivalent pharmacological activity. Flow and compression properties appear suitable for automatic capsule-filling machines, but hydroscopicity and the moisture sensitivity of the phytochemical profile are concerns.

[1]  A. Bilia,et al.  Evaluation of chemical stability of St. John's wort commercial extract and some preparations. , 2001, International journal of pharmaceutics.

[2]  M. Nöldner,et al.  Antidepressant Activity of Hypericum Perforatum and Hyperforin: the Neglected Possibility , 1998, Pharmacopsychiatry.

[3]  S. Gardner,et al.  Content versus label claims in ephedra-containing dietary supplements. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[4]  F. Squadrito,et al.  Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. , 2001, Pharmacopsychiatry.

[5]  F. Panzeri,et al.  Identification by high-performance liquid chromatography–diode array detection–mass spectrometry and quantification by high-performance liquid chromatography–UV absorbance detection of active constituents of Hypericum perforatum , 1998 .

[6]  T. Higuchi,et al.  The physics of tablet compression. IV. Relationship of ejection, and upper and lower punch forces during compressional process: application of measurements to comparison of tablet lubricants. , 1954, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

[7]  R.,et al.  Density-Pressure Relationships in Powder Compaction , 2010 .

[8]  K. Kovar,et al.  Analysis and Stability of Hyperici Oleum , 1992, Planta medica.

[9]  P Eneroth,et al.  What do commercial ginseng preparations contain? , 1994, The Lancet.

[10]  L L Augsburger,et al.  Capsule filling machine simulation. I. Low-force powder compression physics relevant to plug formation. , 1999, Pharmaceutical development and technology.

[11]  P. Turner,et al.  Lorazepam on visuo‐motor co‐ordination and visual function in man , 1973, The Journal of pharmacy and pharmacology.

[12]  G. Herbette,et al.  Pseudohypericin and hypericin in St. John's wort extracts. Breakdown of pseudohypericin , 1999 .

[13]  M. Kontny,et al.  Gelatin capsule brittleness as a function of relative humidity at room temperature , 1989 .

[14]  Larry L. Augsburger,et al.  Hard- and Soft-Shell Capsules , 2002 .

[15]  S. Bhattacharya,et al.  Hyperforin as a possible antidepressant component of hypericum extracts. , 1998, Life sciences.

[16]  D. Meruelo,et al.  Hypericin as an inactivator of infectious viruses in blood components , 1995, Transfusion.

[17]  P. C. Schmidt,et al.  STABILITY AND STABILIZATION OF HYPERFORIN , 1999 .

[18]  Intrinsic flowability: a new technology for powder-flowability classification , 1999 .

[19]  J. C. Callahan,et al.  Equilibrium Moisture Content of Pharmaceutical Excipients , 1982 .

[20]  Kimio Kawakita,et al.  Some considerations on powder compression equations , 1971 .

[21]  M Kieser,et al.  St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. , 1998, Pharmacopsychiatry.

[22]  J. Phillipson,et al.  St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties , 2001, The Journal of pharmacy and pharmacology.

[23]  A. Nahrstedt,et al.  Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. , 2000, Planta medica.

[24]  J. Mathias,et al.  Program , 1970, Symposium on VLSI Technology.

[25]  F. Firenzuoli,et al.  Effects of Hypericum perforatum on Levels of 5‐Hydroxytryptamine, Noradrenaline and Dopamine in the Cortex, Diencephalon and Brainstem of the Rat , 1999, The Journal of pharmacy and pharmacology.

[26]  J. H. Shaxby,et al.  On the properties of powders. The variation of pressure with depth in columns of powders , 1923 .